Home › Autosomal Dominant Polycystic Kidney
Autosomal Dominant Polycystic Kidney clinical trials recruiting in the U.S.
11 studies for Autosomal Dominant Polycystic Kidney are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Bempedoic Acid Therapy for Polycystic Kidney Disease
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 29, 2026 · NCT07282821Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07228364ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Sep 1, 2026 · NCT06902558Managing Depressive Symptoms in ADPKD
Recruiting
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT07745920Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
RecruitingObservational study
Up to age 18 · All sexes · Updated Jun 15, 2026 · NCT04338048Early PKD Observational Cohort Study
RecruitingObservational studyHealthy volunteers welcome
Ages 4 to 35 · All sexes · Updated Apr 27, 2026 · NCT02936791Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
Recruiting
Ages 18 and older · All sexes · Updated Mar 6, 2026 · NCT07454174A Prospective Observational Study of Foam Sclerotherapy .
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Jan 26, 2026 · NCT04111692Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 30 · All sexes · Updated Jan 16, 2026 · NCT04344769NOX4 and Related Biomarkers in ADPKD
RecruitingObservational study
Ages 15 to 40 · All sexes · Updated Jan 9, 2026 · NCT04630613Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated May 6, 2025 · NCT06582875From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.